Study guide

4.2 Patient Counseling Requirements, Offer-to-Counsel & Documentation

NABP MPJE Multistate Pharmacy Jurisprudence Examination Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Pharmacist Licensure & Reciprocity

1.1 Initial Licensure Requirements & Examinations 1.2 License Renewal, Continuing Education (CE) & Status 1.3 Reciprocity, License Transfer & Multistate Licensure 1.4 Disciplinary Actions, Board Hearings, Sanctions & Reinstatement

2 Chapter 2: Pharmacy Personnel Roles & Supervision Ratios

2.1 Pharmacy Interns: Scope of Practice, Supervision & Preceptor Rules 2.2 Pharmacy Technicians: Registration, Certification & Permitted Duties 2.3 Technician-to-Pharmacist Ratios & Delegated Tasks 2.4 Non-Pharmacist Personnel & Automated Dispensing Technology Roles

3 Chapter 3: Prescriptive Authority & Practitioner Categories

3.1 Physicians, Dentists, Veterinarians & Podiatrists: Prescribing Scope 3.2 Mid-Level Practitioners: APNs, PAs, Optometrists & Independent Authority 3.3 Out-of-State, Foreign & Deceased Practitioner Prescriptions 3.4 Self-Prescribing & Prescribing for Family Members

4 Chapter 4: Patient Counseling & Drug Utilization Review (OBRA '90)

4.1 OBRA '90 Mandates & Prospective Drug Utilization Review (DUR) 4.2 Patient Counseling Requirements, Offer-to-Counsel & Documentation 4.3 Patient Profile Requirements & Retrospective DUR

5 Chapter 5: Advanced Pharmacist Practice & Collaborative Agreements

5.1 Collaborative Practice Agreements (CPAs) & Protocol-Based Care 5.2 Pharmacist Immunization Authority & Vaccine Administration Protocols 5.3 Medication Therapy Management (MTM) & Point-of-Care Testing (POCT) 5.4 Hormonal Contraceptive, Naloxone & Post-Exposure Prophylaxis (PEP/PrEP) Prescribing

6 Chapter 6: Federal Controlled Substances Act (CSA) & Scheduling

6.1 Controlled Substance Schedules (CI through CV) & Classification Criteria 6.2 DEA Registration: Types, Forms (224, 225, 363) & Renewal Cycles 6.3 Scheduled Listed Chemical Products (SLCPs) & Combat Methamphetamine Epidemic Act (CMEA)

7 Chapter 7: Controlled Substance Prescriptions & Legitimate Purpose

7.1 Corresponding Responsibility & Red Flags for Improper Prescribing 7.2 Required Components of Controlled Substance Prescriptions 7.3 Electronic Prescriptions for Controlled Substances (EPCS) & Security Requirements 7.4 Emergency Schedule II Prescriptions & Partial Filling Rules (CARA Act)

8 Chapter 8: Controlled Substance Ordering, Inventory & Recordkeeping

8.1 Ordering Schedule II Substances: CSOS & DEA Form 222 Execution 8.2 Controlled Substance Inventory Requirements (Initial, Biennial, Count Exactness) 8.3 Theft, Significant Loss (DEA Form 106) & Disposal/Destruction (DEA Form 41) 8.4 Prescription Transfers & Prescription Drug Monitoring Programs (PDMPs)

9 Chapter 9: Federal Pure Food, Drug & Cosmetic Act (FD&C Act) & Drug Safety

9.1 Adulteration vs. Misbranding: Statutory Definitions & Legal Violations 9.2 Prescription Labeling Requirements, Expiration Dates & Side Effect Statements 9.3 Poison Prevention Packaging Act (PPPA) & Child-Resistant Container Exemptions 9.4 Drug Recalls (Class I, II, III) & Market Withdrawals 9.5 Drug Product Selection, Generic Substitution & DAW Codes 9.6 Returning & Reusing Dispensed Drugs: Restocking, Redispensing & Repository Programs

10 Chapter 10: Drug Supply Chain Security Act (DSCSA) & Commercial Distribution

10.1 DSCSA Track-and-Trace Requirements: Transaction Information & Statements 10.2 Suspect & Illegitimate Product Verification, Quarantine & Notification 10.3 Prescription Drug Marketing Act (PDMA): Samples, Reimportation & Wholesale Distribution

11 Chapter 11: Compounding Standards: USP <795>, <797> & <800>

11.1 Section 503A vs. 503B Compounding Facilities (DQSA Architecture) 11.2 Non-Sterile Compounding (USP <795>) & Beyond-Use Dating (BUD) 11.3 Sterile Compounding (USP <797>): Air Quality, Cleanrooms & BUD 11.4 Hazardous Drug Handling (USP <800>): Engineering Controls & Personal Protective Equipment

12 Chapter 12: Pharmacy Operational Security, Records & Telepharmacy

12.1 Physical Pharmacy Security, Alarm Systems & Keyholder Rules 12.2 Mandatory Pharmacy Records Retention & Audit Inspection Readiness 12.3 Central Fill, Automated Dispensing Systems (ADS) & Telepharmacy Operations 12.4 HIPAA Privacy Rule, Patient Records & Breach Notification Protocols

4.2 Patient Counseling Requirements, Offer-to-Counsel & Documentation

Key Takeaways Explain This Topic AI

OBRA '90 mandates an active, verbal offer to counsel for every new prescription filled in a community pharmacy setting.

While ancillary staff (cashiers, pharmacy technicians) may verbally extend the offer to counsel in many jurisdictions, only a licensed pharmacist or supervised pharmacy intern may actually provide drug counseling.

Patient counseling must cover key operational and clinical elements, including drug name, dosing, route, administration technique, severe adverse effects, self-monitoring, storage, refills, and missed dose actions.

Patients retain the legal right to refuse counseling; however, the pharmacy must explicitly document any counseling refusal in the patient profile or prescription record.

For mail-order or delivery prescriptions, an offer to counsel must be provided in writing alongside a toll-free telephone number allowing direct patient access to a pharmacist.

Last updated: July 2026

4.2 Patient Counseling Requirements, Offer-to-Counsel & Documentation

Patient counseling is one of the pivotal duties of a registered pharmacist. Under the Omnibus Budget Reconciliation Act of 1990 (OBRA '90) and state pharmacy practice acts, the dispensing of a prescription is incomplete without fulfilling the statutory obligations regarding the offer to counsel and the provision of professional drug information.

While federal OBRA '90 regulations mandated patient counseling standards for Medicaid beneficiaries, state pharmacy boards adopted these requirements across all practice settings for all patients receiving outpatient prescription drugs .

The Mandatory Offer to Counsel

Under OBRA '90 standards, an active offer to counsel must be made to the patient or the patient's caregiver whenever a new prescription is presented for dispensing.

Active Offer vs. Passive Notice

A central concept tested on the MPJE is the strict legal distinction between an active offer and a passive notice :

Active Offer (Required): The pharmacy staff must directly, verbally communicate the offer to the patient or caregiver at the point of sale (e.g., asking verbally: "The pharmacist is available to go over your new medication with you today, would you like to speak with them?" ).

Passive Notice (Prohibited as Primary Offer): Posting a sign on the pharmacy wall stating "Inform the Pharmacist If You Desire Counseling," printing a notice on a paper receipt, or handing the patient a written flyer does NOT satisfy the legal requirement for face-to-face transactions in an outpatient pharmacy setting.

Scope of Personnel: Who Can Offer vs. Who Can Counsel

State pharmacy practice acts strictly delineate the duties of pharmacy personnel regarding patient counseling. Misassignment of these duties is a frequent source of pharmacy board disciplinary actions.

1. Ancillary Personnel (Pharmacy Technicians, Cashiers, Clerks)

Permitted Action: In many jurisdictions, pharmacy technicians, cashiers, or clerks are legally permitted to extend the verbal offer to counsel to the patient at the register (e.g., asking if the patient wants counseling).

Prohibited Action: Ancillary personnel are strictly prohibited from performing actual patient counseling, answering clinical questions, evaluating drug safety, explaining side effects, or advising patients on how to take their medications.

2. Licensed Pharmacists and Supervised Pharmacy Interns

Permitted Action: Only a licensed pharmacist or a registered pharmacy intern acting under the direct, personal supervision of a licensed pharmacist may perform clinical patient counseling.

Clinical Responsibility: The counseling individual must exercise professional judgment to tailor the discussion to the patient's literacy level, health condition, and specific drug therapy needs.

Mandatory Counseling Topics Under OBRA '90

OBRA '90 outlines eight specific matters that the pharmacist must review with the patient when conducting a counseling session. While the pharmacist retains professional discretion to determine which specific topics are clinically relevant for a given scenario, the baseline curriculum of counseling includes:

Name and Description of Medication: Generic name, brand/trade name, therapeutic class, and prescribed indication.

Dosage Form, Dose, Route, and Duration: Specific dosage form (e.g., extended-release tablet), exact dose, administration route (e.g., oral, topical, ophthalmic), and total planned duration of therapy.

Special Directions and Administration Precautions: Technique-specific instructions (e.g., priming an inhaler, applying a transdermal patch, shaking suspensions), self-administration timing, and dietary restrictions (e.g., taking with food, avoiding grapefruit juice).

Common Severe Side Effects and Adverse Reactions: Significant adverse effects, drug-drug or drug-food interactions, therapeutic contraindications, and actionable guidance on how to prevent or manage them.

Techniques for Self-Monitoring: Instructions on how the patient can monitor therapeutic efficacy or adverse effects at home (e.g., checking blood pressure, monitoring blood glucose logs, tracking peak flow).

Proper Storage Requirements: Environmental storage conditions necessary to maintain drug potency and stability (e.g., refrigeration between 36°F–46°F, protection from light, keeping away from bathroom humidity).

Prescription Refill Information: Number of authorized refills remaining and process for requesting subsequent fills.

Action Taken in Event of Missed Dose: Clear, actionable instructions on what the patient should do if a dose is skipped or forgotten (e.g., take as soon as remembered unless close to next scheduled dose; never double up doses).

  • Special Practice Settings: Mail-Order, Delivery, & Inpatient Exemptions
  • Mail-Order and Delivery Prescriptions

When a prescription is delivered to the patient via postal mail, parcel delivery, or pharmacy courier—where face-to-face contact is impossible—OBRA '90 and state rules mandate alternative counseling protocols:

A written offer to counsel must be included with the delivered medication package.

The package must contain written patient educational materials detailing key drug information.

The pharmacy must provide a toll-free telephone number printed on the prescription container label or accompanying paperwork, providing direct access to a pharmacist during normal operating hours (typically required to operate at least 6 days or 40 hours per week).

Inpatient Institutional Exemption

OBRA '90 patient counseling requirements generally do NOT apply to hospital inpatients or institutional residents where medications are administered directly by licensed healthcare professionals (e.g., registered nurses). The exemption applies because healthcare professionals supervise administration and monitor for adverse effects continuously. However, outpatient prescriptions dispensed to hospital employees or patients upon discharge do require full OBRA '90 offer-to-counsel protocols.

  • Patient Refusal Rights & Documentation Standards
  • Right to Refuse Counseling

Under federal and state law, a patient (or their authorized representative) maintains the absolute right to refuse or decline patient counseling. A pharmacist cannot force counseling upon an unwilling patient.

Mandatory Documentation of Refusal

When a patient declines counseling, the pharmacy must document the refusal contemporaneously in the pharmacy record system or on the prescription log.

Record Retention: Documented counseling refusals (and records of completed counseling) must be retained for the state-mandated record retention period—typically at least 2 years from the dispensing date.

Legal Presumption on MPJE: In pharmacy malpractice litigation or board compliance audits, if there is no written or electronic record of a refusal , state law creates a legal presumption that the pharmacy failed to extend the offer to counsel , exposing the pharmacy and pharmacist to severe regulatory sanctions and civil liability.

Summary Table: Roles in Patient Counseling

Role / Personnel Extend Offer to Counsel? Conduct Clinical Counseling? Document Refusal?

  • Cashier / Clerk YES (Verbal offer permitted) NO (Strictly prohibited) YES (Entry into system permitted)
  • Pharmacy Technician YES (Verbal offer permitted) NO (Strictly prohibited) YES (Entry into system permitted)
  • Pharmacy Intern YES YES (Under direct RPh supervision) YES
  • Licensed Pharmacist YES YES (Independent professional duty) YES
  • Summary Table: The 8 Mandatory OBRA '90 Counseling Topics
  • Topic Area Essential Information to Communicate
  • 1. Drug Name & Description Brand/generic names, strength, and intended clinical use
  • 2. Dosing & Route Exact dose quantity, route of administration, duration of therapy
  • 3. Administration Directions Special prep, shaking suspensions, inhaler priming, meal timing
  • 4. Adverse Effects & Risks Common/severe side effects, interactions, and management steps
  • 5. Self-Monitoring Blood glucose, blood pressure, or symptom tracking techniques
  • 6. Storage Conditions Refrigeration, room temp, humidity avoidance, child-safety
  • 7. Refill Guidelines Remaining authorized fills and re-ordering procedures
  • 8. Missed Dose Instructions Specific action steps when a dose is missed; avoid doubling doses

Loading diagram... Offer-to-Counsel & Counseling Decision Tree at Register